These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30926167)

  • 1. Lovastatin attenuates angiotensin II induced cardiovascular fibrosis through the suppression of YAP/TAZ signaling.
    Wu P; Liu Z; Zhao T; Xia F; Gong L; Zheng Z; Chen Z; Yang T; Duan Q
    Biochem Biophys Res Commun; 2019 May; 512(4):736-741. PubMed ID: 30926167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of angiotensin II activation of yes-associated protein/PDZ-binding motif signaling in hypertensive cardiac and vascular remodeling.
    Xu Q; Zhuo K; Zhang X; Zhen Y; Liu L; Zhang L; Gu Y; Jia H; Chen Q; Liu M; Dong J; Zhou MS
    Eur J Pharmacol; 2024 Jan; 962():176252. PubMed ID: 38061470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration.
    Liu C; Cheng X; Chen J; Wang Y; Wu X; Tian R; Liu B; Ding X; Sun Q; Gong W
    Theranostics; 2019; 9(13):3840-3852. PubMed ID: 31281517
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin II depends on hippo/YAP signaling to reprogram angiogenesis and promote liver fibrosis.
    Zhou Y; Liang P; Bi T; Tang B; Zhu X; Liu X; Wang H; Shen H; Sun Q; Yang S; Ren W
    Cell Signal; 2024 Nov; 123():111355. PubMed ID: 39173854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction.
    Mia MM; Cibi DM; Abdul Ghani SAB; Song W; Tee N; Ghosh S; Mao J; Olson EN; Singh MK
    PLoS Biol; 2020 Dec; 18(12):e3000941. PubMed ID: 33264286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yes-associated protein and transcriptional coactivator with PDZ-binding motif as new targets in cardiovascular diseases.
    Yu Y; Su X; Qin Q; Hou Y; Zhang X; Zhang H; Jia M; Chen Y
    Pharmacol Res; 2020 Sep; 159():105009. PubMed ID: 32553712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis.
    Mooring M; Fowl BH; Lum SZC; Liu Y; Yao K; Softic S; Kirchner R; Bernstein A; Singhi AD; Jay DG; Kahn CR; Camargo FD; Yimlamai D
    Hepatology; 2020 May; 71(5):1813-1830. PubMed ID: 31505040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The signaling protein Wnt5a promotes TGFβ1-mediated macrophage polarization and kidney fibrosis by inducing the transcriptional regulators Yap/Taz.
    Feng Y; Liang Y; Zhu X; Wang M; Gui Y; Lu Q; Gu M; Xue X; Sun X; He W; Yang J; Johnson RL; Dai C
    J Biol Chem; 2018 Dec; 293(50):19290-19302. PubMed ID: 30333225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis.
    Toyama T; Looney AP; Baker BM; Stawski L; Haines P; Simms R; Szymaniak AD; Varelas X; Trojanowska M
    J Invest Dermatol; 2018 Jan; 138(1):78-88. PubMed ID: 28870693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.
    Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
    Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
    Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer.
    Xiao Y; Liu Q; Peng N; Li Y; Qiu D; Yang T; Kang R; Usmani A; Amadasu E; Borlongan CV; Yu G
    Cell Transplant; 2022; 31():9636897221075749. PubMed ID: 35168393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease.
    Ou W; Xu W; Liu F; Guo Y; Huang Z; Feng T; Liu CY; Du P
    EBioMedicine; 2021 Jul; 69():103452. PubMed ID: 34186485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yap/Taz Deletion in Gli
    Liang M; Yu M; Xia R; Song K; Wang J; Luo J; Chen G; Cheng J
    J Am Soc Nephrol; 2017 Nov; 28(11):3278-3290. PubMed ID: 28768710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review on decoding the roles of YAP/TAZ signaling pathway in cardiovascular diseases: Bridging molecular mechanisms to therapeutic insights.
    Zhang Y; Ren Y; Li X; Li M; Fu M; Zhou W; Yu Y; Xiong Y
    Int J Biol Macromol; 2024 Jun; 271(Pt 2):132473. PubMed ID: 38795886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP/TAZ activation mediates PQ-induced lung fibrosis by sustaining senescent pulmonary epithelial cells.
    Yu Y; Chu C; Wang K; Li Y; Mao Z; Hu L; Wang J; Yu Y; Sun H; Chen F
    Respir Res; 2024 May; 25(1):212. PubMed ID: 38762455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model.
    Lee J; Jung Y; Jeong SW; Jeong GH; Moon GT; Kim M
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function.
    Mia MM; Cibi DM; Ghani SABA; Singh A; Tee N; Sivakumar V; Bogireddi H; Cook SA; Mao J; Singh MK
    Cardiovasc Res; 2022 Jun; 118(7):1785-1804. PubMed ID: 34132780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis.
    Haak AJ; Kostallari E; Sicard D; Ligresti G; Choi KM; Caporarello N; Jones DL; Tan Q; Meridew J; Diaz Espinosa AM; Aravamudhan A; Maiers JL; Britt RD; Roden AC; Pabelick CM; Prakash YS; Nouraie SM; Li X; Zhang Y; Kass DJ; Lagares D; Tager AM; Varelas X; Shah VH; Tschumperlin DJ
    Sci Transl Med; 2019 Oct; 11(516):. PubMed ID: 31666402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice.
    Moya IM; Castaldo SA; Van den Mooter L; Soheily S; Sansores-Garcia L; Jacobs J; Mannaerts I; Xie J; Verboven E; Hillen H; Algueró-Nadal A; Karaman R; Van Haele M; Kowalczyk W; De Waegeneer M; Verhulst S; Karras P; van Huffel L; Zender L; Marine JC; Roskams T; Johnson R; Aerts S; van Grunsven LA; Halder G
    Science; 2019 Nov; 366(6468):1029-1034. PubMed ID: 31754005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.